Across TCGA pan-cancer cohorts, ARSDP1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ARSDP1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ARSDP1 RNA is repressed in tumor relative to normal tissue. In most cancer types ARSDP1 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and KICH are the cancer types where ARSDP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARSDP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.363	<.001	8	view →
KIRP	Male	All	−0.523	<.001	6	view →
KICH	Male	III,IV	−0.385	.002	5	view →
CHOL	Male	All	+0.415	.015	2	view →
LUAD	Male	III,IV	−0.244	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: ARSDP1 RNA expression & survival · all ARSDP1 data types